Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
about
Exposure to Agrochemicals and Cardiovascular Disease: A ReviewCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationIssues raised involving the copper hypotheses in the causation of Alzheimer's diseaseDisturbed copper bioavailability in Alzheimer's diseaseCopper phenotype in Alzheimer's disease: dissecting the pathwayEffects of Copper and/or Cholesterol Overload on Mitochondrial Function in a Rat Model of Incipient NeurodegenerationCopper and iron in Alzheimer's disease: a systematic review and its dietary implications.Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients.Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's diseaseOverexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders.Role of copper and cholesterol association in the neurodegenerative process.Oxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling.High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics.Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.Copper and its complexes in medicine: a biochemical approach.Effects of copper overload in P19 neurons: impairment of glutathione redox homeostasis and crosstalk between caspase and calpain protease systems in ROS-induced apoptosis.Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studiesAssociation between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.Evaluation of a prototype point-of-care instrument based on monochromatic x-ray fluorescence spectrometry: potential for monitoring trace element status of subjects with neurodegenerative disease.Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis.Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism.Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.Effects of Intermittent and Continuous Magnetic Fields on Trace Element Levels in Guinea Pigs.Copper and ceruloplasmin abnormalities in Alzheimer's disease.Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
P2860
Q26768445-BCF84718-5A87-4B5D-9A2C-8FC1779C7A46Q28087030-9731ED42-1C95-4C16-B6D2-EB415E0B2D24Q28248217-D1BEE2BC-5A84-43C5-88D8-C66266A06E2AQ28254726-5C15974C-7547-4B4E-B97E-1E8A835A6550Q28294380-4BAC3725-9F71-4712-8167-4538CB106599Q28391507-32BB43E6-C6C8-41AF-9133-F04868E63FE1Q34201410-43BE4572-E3FF-49C6-8626-531FAC326FDAQ35226905-093159BD-FDA1-427C-8849-CF26B58B15A4Q35626417-EEEBA752-4BE3-42EF-A0FF-8959BAF35D84Q35696249-5DDB4B49-06F6-460D-9086-FADE1F3C6CF3Q36275015-4E13FBD7-8C9F-4A99-8ABF-C20863ED37B5Q37316130-0FD3810B-08BF-4547-BD61-183D724BB415Q37563576-1EFF3FC7-B1AD-49FF-9184-4F8AD80B2CAFQ37592097-C3892860-D3D8-46E6-A1F9-69148298BEC4Q37737068-C059CB29-501C-4E57-A861-FA807E0F9FECQ38125769-884AD67E-526F-4695-A6E6-F02EB76D2A9AQ38362089-C592EED7-25AA-408D-9F65-0B21A24C2CD9Q38730238-7682F5D7-E636-4A60-BB45-C9B6F267C1C9Q38957058-D032FC30-65E2-41D2-8D2C-AEACDB08567DQ40032173-4AD7BE01-E2EF-4D26-8694-8887B996E350Q41339641-FB435FD3-B432-4536-BA15-E12B8881A56BQ42791835-99A9E24F-9D7F-4828-B7DC-B6BE4B100E47Q43551249-B4AB4072-6188-4B4F-9CE5-20431552F684Q43712169-A25DE763-2514-4D06-A522-3B620825BFC2Q45898364-D372AC7E-2F0C-4A51-BA04-9C320A54173CQ47611418-93244B23-9B84-457A-A213-8460B8FDCBECQ47710744-503BF8F1-1209-46C5-A4DB-DA90CA44E8B0Q47947787-2762E70C-3008-45AB-B68C-A1467855B316Q48341689-DB215DDB-0AED-46BB-9B05-27AFBE1F9853Q52094033-B8634618-2022-48C5-A068-BA7B46C7DB3AQ53311361-80D86212-37ED-47DB-9FC7-60958D8F420DQ53485291-6B51AF7B-C591-4CB8-956F-32F233D45F1B
P2860
Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clinical utility of copper, ce ...... their first-degree relatives.
@en
Clinical utility of copper, ce ...... their first-degree relatives.
@nl
type
label
Clinical utility of copper, ce ...... their first-degree relatives.
@en
Clinical utility of copper, ce ...... their first-degree relatives.
@nl
prefLabel
Clinical utility of copper, ce ...... their first-degree relatives.
@en
Clinical utility of copper, ce ...... their first-degree relatives.
@nl
P2093
P1433
P1476
Clinical utility of copper, ce ...... their first-degree relatives.
@en
P2093
Carlos Alberto Marra
Diana Olga Cristalli
María J T de Alaniz
Nathalie Arnal
P304
P356
10.1016/J.BRAINRES.2009.11.085
P407
P577
2009-12-22T00:00:00Z